Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Costs and Cascade Health Service Use as a Consequence of Whole Genome Sequencing in Children with a Cardiomyopathy and their Families
EF 2018-19
Résumé
Whole exome sequencing (WES) and whole genome sequencing (WGS) are able to identify a wide range of genetic abnormalities, and as such are powerful new tools in human and medical genetics research. However, WES/WGS raises a multitude of ethical difficulties because, by its nature, it generates secondary findings – supplemental data not relevant to the initial diagnostic query. The challenges posed by these secondary findings are exacerbated in the paediatric context, where patients are often unable to give informed consent.
There have been no economic analyses conducted specifically for the generation and return of secondary findings from paediatric WES/WGS, nor have there been economic studies of the effects of cascading genetic tests in family members of a child with a positive WES/WGS. The Genome Clinic at the Hospital for Sick Children (SickKids) already returns secondary results from paediatric WGS to parents, however there is little consideration of the impact of downstream cascade testing and service use on the health care system. We will fill this knowledge gap by conducting an economic analysis using the tools and methods of Health Technology Assessment, exploring the cascade use of health services and costs as a consequence of whole genome sequencing in the paediatric cardiomyopathy population.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
417980
Name
Cernat Alexandra
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Costs and Cascade Health Service Use as a Consequence of Whole Genome Sequencing in Children with a Cardiomyopathy and their Families
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cost-Value Analysis; Economic Evaluation; Genes; Genetic Testing; Health Economics; Paediatrics; Whole Genome Sequencing
Abstract
Whole exome sequencing (WES) and whole genome sequencing (WGS) are able to identify a wide range of genetic abnormalities, and as such are powerful new tools in human and medical genetics research. However, WES/WGS raises a multitude of ethical difficulties because, by its nature, it generates secondary findings – supplemental data not relevant to the initial diagnostic query. The challenges posed by these secondary findings are exacerbated in the paediatric context, where patients are often unable to give informed consent.
There have been no economic analyses conducted specifically for the generation and return of secondary findings from paediatric WES/WGS, nor have there been economic studies of the effects of cascading genetic tests in family members of a child with a positive WES/WGS. The Genome Clinic at the Hospital for Sick Children (SickKids) already returns secondary results from paediatric WGS to parents, however there is little consideration of the impact of downstream cascade testing and service use on the health care system. We will fill this knowledge gap by conducting an economic analysis using the tools and methods of Health Technology Assessment, exploring the cascade use of health services and costs as a consequence of whole genome sequencing in the paediatric cardiomyopathy population.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cernat, Alexandra
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~